Gatifloxacin

Zymar

0.3 % / W/V SolutionCanadaMarketedAuthorised 27 Sept 2004

In other countries

The same active substances on other registers, the same brand first.

ZymarBrazil · Allergan Produtos Farmacêuticos LtdaSame brand
Zymar 0.3% Ophthalmic SolutionSaudi Arabia · Allergan Pharmaceuticals LTDSame brand
Zymar Ophthalmic Solution 0.3%Singapore · 3 mg/ml · solution · Abbvie Pte. LTD.Same brand
ZymarUnited States · 0.3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · solution/drops · AllerganSame brand
GatifloxacinUnited States · 0.3%, 0.5% · solution/drops · CaplinSame form
ZymaxidUnited States · 0.5% · solution/drops · AbbvieSame form
gatifloxacinoBrazil · Geolab Indústria Farmacêutica S/ASame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Gatifloxacin

Zymar

0.3 % / W/V SolutionCanadaMarketedAuthorised 27 Sept 2004

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

OrbifloxBrazil · Geolab Indústria Farmacêutica S/A

Tymer 0.3% Eye DropSaudi Arabia · Jamjoom Pharmaceuticals Company

ZYMAXID 0.5% eye drops solutionSaudi Arabia · Allergan

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Gatifloxacin
Strength: 0.3 % / W/V
Dosage form: Solution
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Marketed
Authorised: 27 Sept 2004
Registration: DIN 02257270
Marketing authorisation holder: Abbvie Corporation
ATC code: S01AE06
Group: Sensory organs
Supply: PRESCRIPTION

Novo-GatifloxacinGatifloxacin · 400 MG · TabletCanadaCancelled

Sandoz GatifloxacinGatifloxacin · 3 MG / ML · SolutionCanadaCancelled

TequinGatifloxacin · 400 MG · TabletCanadaCancelled

TequinGatifloxacin · 200 MG · TabletCanadaCancelled

Tequin IVGatifloxacin · 10 MG / ML · LiquidCanadaCancelled

Tequin IVGatifloxacin · 2 MG / ML · SolutionCanadaCancelled